focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Launch of Commercial R&D Partnership Service

8 Oct 2020 07:00

RNS Number : 4412B
Applied Graphene Materials PLC
08 October 2020
 

08 October 2020

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "AGM" or "the Group")

 

AGM launches unique Innovation Accelerator research and development partnership service

 

Applied Graphene Materials, the producer of speciality graphene nanoplatelet dispersions, has launched a new commercial service offering. 'Innovation Accelerator' is a unique end-to-end research and development service to support businesses in harnessing the potential of graphene in their products.

 

Through Innovation Accelerator, AGM's unique offering can support customers through to product launch with this end-to-end service. The programme offers customers a range of innovative solutions, from exclusive graphene enhanced dispersions tailored for their system, to working directly with AGM's technical experts to develop a customised project, formulation services and full system application testing and product characterisation.

 

Innovation Accelerator represents a potential new revenue stream for AGM and acknowledges its high-value support to customers during their product development phase, which can often last months. Partners will pay a one-off fee for a package to include research and development, quality control testing, on-going stability trials and a starter kit of a graphene dispersion. Tailored dispersions made to customers' product specifications are priced separately.

 

The Innovation Accelerator offering will be made available to existing commercial partners as well as to companies with whom AGM is not yet formally engaged, and will be actively marketed via AGM's distribution network which now spans the majority of Europe, North America, and Japan.

 

Adrian Potts, Chief Executive Officer of AGM, said:

 

"The exciting product launches of our customers in recent days and months have been the result of extensive testing and collaboration with AGM's outstanding technicians, who have developed unique proprietary IP in graphene dispersion and application. Without their ongoing support it would simply not have been possible for many of these ground-breaking, graphene-enhanced products to be brought to market so quickly, allowing our customers an early competitive advantage over their industry peers. I am confident that the formal launch of our Innovation Accelerator service will support growing momentum of product development both with AGM's existing and new customers across the world, and I would like to pay tribute to the great skill and hard work of our talented team."

 

 

For further information please contact:

 

Applied Graphene Materials

+44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer 

David Blain, Chief Financial Officer

 

N+1 Singer

+44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Hudson Sandler

 +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

Notes to Editors:

 

Applied Graphene Materials - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Their expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way.

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016 and a further £9.8m in November 2017. Since August 2020, the Group's shares are also listed on OTCQX in the United States. As a result of the funding support and their industry leading technology platform, AGM have been able to develop a significant sales distribution network covering Europe, North America and a partner in Japan. The Group continues to work closely with industrial partners, and have seen the successful launch of numerous commercial products enhanced by their Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

 

Innovation Accelerator services include:

 

Customised Dispersion - AGM offers the development of customised graphene-based dispersion in the solvent or liquid resin system as specified by the customer. These are optimised, stable and easy to use dispersions and are exclusively available for the specific customer.

 

Customer Formulation Development - AGM chemists work directly with the customer's formulations, creating a series of optimised graphene containing options ready for development and product testing.

 

Customised Product Testing Programme - AGM can share the testing burden to help accelerate development and ensure the quick route to market for the new products.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMRBMTMTAMTBM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.